A Descriptive Review of Global Real World Evidence Efforts to Advance Drug Discovery and Clinical Development in Amyotrophic Lateral Sclerosis
Understanding patient clinical progression is a key gateway to planning effective clinical trials and ultimately enabling bringing treatments to patients in need. In a rare disease like amyotrophic lateral sclerosis (ALS), studies of disease natural history critically depend on collaboration between...
Guardado en:
Autores principales: | Suzanne F. Cook, Thomas Rhodes, Courtney Schlusser, Steve Han, Chao Chen, Neta Zach, Venkatesha Murthy, Shreya Davé |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/67fe608696cf4764bc9d225c3674bd2f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Amyotrophic lateral sclerosis official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
Publicado: (2006) -
Amyotrophic lateral sclerosis and frontotemporal degeneration
Publicado: (2000) -
Amyotrophic lateral sclerosis and other motor neuron disorders official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
Publicado: (2005) -
γ' Fibrinogen as a Predictor of Survival in Amyotrophic Lateral Sclerosis
por: Ana Catarina Pronto-Laborinho, et al.
Publicado: (2021) -
Corrigendum: γ′ Fibrinogen as a Predictor of Survival in Amyotrophic Lateral Sclerosis
por: Ana Catarina Pronto-Laborinho, et al.
Publicado: (2021)